A patient with Type 2 diabetes who is admitted to the hospital may be managed with a basal-bolus insulin regimen. Umpierrez described one such regimen consisting of an initial regimen with subsequent dosage adjustments. The authors are from Emory University and the University of Miami and participated in the RABBIT-2 Trial.
